Sekar Kathiresan

Dec 11, 2023 | medscape.com | Michelle L. O'Donoghue |Sekar Kathiresan

This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. I'm here at the American Heart Association meeting, and one of the interesting stories that we're going to be talking about is that of gene editing. Joining me to discuss this is Dr Sekar Kathiresan. He's the co-founder and the chief executive officer of Verve, and they presented some very interesting results.